Coronavirus News and Research

RSS

Free open source hardware could be used to fight against coronavirus

Free open source hardware and 3D printing could help to alleviate the burden of Covid-19 on global health systems, according to scientists at the University of Sussex.

27 Apr 2020

Researchers re-purpose cancer-fighting artificial antibodies for COVID-19

Researcher Paula Bates, John Trent, and Don Miller developed a therapeutic drug that could potentially block the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the COVID-19 pandemic. Their research was initially aimed at helping patients suffering from multiple types of cancer.

27 Apr 2020

Rice University looks to ‘trap and zap’ SARS-CoV-2 in wastewater

A team of researchers from Rice University has won a National Science Foundation (NSF) RAPID grant to adapt their wastewater nanotechnology project to help trap and inactivate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), (which causes COVID-19 disease), in wastewater. This could help public health officials deal with the threat of disease transmission through wastewater.

27 Apr 2020

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

A new study reports the induction of high levels of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing the current pandemic of COVID-19. This promising finding was reported on the preprint server bioRxiv on April 2020.

26 Apr 2020

The 'true' infection fatality rate of the earliest Italian COVID-19 outbreak

In the chaotic healthcare situation caused by the novel coronavirus disease COVID-19, it has been challenging to estimate the actual severity of the disease. However, it is a crucial bit of information for those who form healthcare and economic policies.

26 Apr 2020

Is the BCG vaccine really protective against COVID-19?

A new paper published on the preprint server medRxiv in April 2020 challenges the hypothesis that BCG vaccination confers some degree of protection against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the pneumonic illness COVID-19.

26 Apr 2020

Oncologist and mum-to-be chronicles COVID-19 experiences

Writing in the latest issue of JAMA Oncology researcher Coral Olazagasti along with her Dr. Nagashree Seetharamu from Zucker School of Medicine at Hofstra, Northwell Health, Hempstead, New York, spoke about her experience being pregnant during the present COVID-19 pandemic. Olazagasti’s chronicle is titled “Facing a pandemic while pregnant.”

26 Apr 2020

Women more concerned about COVID 19

Studies have revealed that men seem to be more at risk of getting severe effects of the COVID-19 infection compared to women. Studies also show that women seem to be worrying more about getting infected than men. Both these findings may be related to each other.

26 Apr 2020

Microclimate and turbulent wind can influence COVID-19 spread over long distances

Respiratory particles exhaled after a sneeze can be transported by the turbulent wind more than three times further than current social or physical distancing measures recommend, reports a new study from Chile available on the preprint server medRxiv.

26 Apr 2020

Mapping complex peripheral immune response to severe COVID-19

In a recent article publicly available at medRxiv, researchers from Stanford have presented a single-cell atlas of the peripheral immune response to coronavirus disease (COVID-19), highlighting pertinent immunological features associated with the severe forms of the disease.

26 Apr 2020

Early Heparin therapy improves hypoxia in COVID-19 patients

The systemic use of heparin for treating severe coronavirus disease (COVID-19) showed significant improvements in oxygen exchange and overall clinical presentation of patients, as reported by a study from Brazil available on a preprint server medRxiv.

26 Apr 2020

New Nightingale hospital uses the G210 to help set up its 500 beds

The new Nightingale hospital, opened in Harrogate, used the G210, supplied by Bedfont, to validate the piped gas needed for its additional 500 beds

From Bedfont® Scientific Ltd 25 Apr 2020

Annals of Internal Medicine: COVID-19 and other health system catastrophes

Below please find a summary and link(s) of new coronavirus-related content published today in Annals of Internal Medicine.

25 Apr 2020

Misinformation on COVID-19 is tied to media usage

People who relied on conservative media or social media in the early days of the COVID-19 outbreak were more likely to be misinformed about how to prevent the virus and believe conspiracy theories about it, a study of media use and public knowledge has found.

25 Apr 2020

New antibody test to identify individuals infected with COVID-19 virus

Several tests have been developed for detecting the genetic material of the SARS-CoV-2 coronavirus that causes COVID-19, but these generally only allow detection of the virus during acute infection.

25 Apr 2020

Shortage of coronavirus 'cure' puts pregnant lupus sufferers and their babies at risk

Pregnant lupus sufferers and their babies are at risk as global supplies of an anti-malarial medicine used to treat the disease run dry due to COVID-19 panic.

24 Apr 2020

Resurgence of measles or polio outbreaks likely to happen, experts warn

Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn.

24 Apr 2020

Indiana State Department of Health and IU collaborate to study COVID-19 spread

The Indiana State Department of Health is collaborating with the Indiana University Richard M. Fairbanks School of Public Health at IUPUI to conduct a scientific study to measure the spread of COVID-19 throughout the state.

24 Apr 2020

FAU scientists aim to develop a passive vaccine against COVID-19

Nothing less than the development of a passive vaccine against Covid-19 has been undertaken by a team of scientists from Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinkum Erlangen and their partners from the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig and the German Primate Centre in Göttingen.

24 Apr 2020